SCHEMBL7229244

SCHEMBL7229244

[CH2]C=C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL250546 1.00
SCHEMBL7444509 0.67
SCHEMBL8353163 0.67
SCHEMBL11003435 0.63
SCHEMBL11127624 0.63
SCHEMBL1499187 0.59
Ethylene SCHEMBL5620013 0.59
Ethylene SCHEMBL4579824 0.59
Ethylene SCHEMBL635893 0.59
SCHEMBL232975 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6664253-B2 N-phenethyl-2-aryl-2-(4-(oxy-or amino-carbonylamino)piperidin-1-yl)acetamide derivatives BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-12-16 US claimed
US-20020115666-A1 Neurokinin antagonists BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2002-08-22 US claimed
US-6664253-B2 N-phenethyl-2-aryl-2-(4-(oxy-or amino-carbonylamino)piperidin-1-yl)acetamide derivatives BOEHRINGER INGELHEIM PHARMA KG (DE) 2003-12-16 US disclosed
US-20020115666-A1 Neurokinin antagonists BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2002-08-22 US disclosed